Index

By TNW

About Index Trending news Pricing

Sign up or sign in

Exelixis

Work at Exelixis? Add yourself to this profile

3726

Exelixis

Edit Profile

exelixis.com
Technology > Biotechnology
B2c
Founded in 1994

More info

Elsewhere

Also headquartered in San Francisco

Companies in the same industry

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Employees

Team size

200+

Locations

HQ

San Francisco, United States

Headquarters

Exelixis, Inc. Setting New Standard of Care

Exelixis, Inc. Gets Some ASCO Love

Health

Exelixis, Inc. Rides Cabometyx's Coattails to Big Gains in May

These 2 Billionaires Are Dumping Exelixis' Stock. Should You?

Stock markets

This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales

Exelixis, Inc. Prepares for Blastoff

Health Announcements

2 Big Reasons Why Shares of Exelixis, Inc. Soared 15% in April

Health Stock markets Earnings

Better Buy: Exelixis, Inc. vs. Roche

Exelixis, Inc.'s Cabometyx Approved: Let the Kidney Cancer Battle Begin!

Health

Exelixis, Inc.'s EKG-Like Stock Chart Hits a Low Spot

Stock markets Health

Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb

Why Exelixis' Stock Dropped 10% on Tuesday

Exelixis, Inc. Partnering Before Approval

Health

Exelixis Inc. Stock Was Throttled in February -- Here's Why

On Comeback Trail, Exelixis Reels In $200M Deal For Cancer Drug

Health Earnings

Emotional Investing Deflates Exelixis, Inc. in January

Why Exelixis, Inc. Rocketed Higher on Friday

Stock markets Health

Exelixis, Inc. Nearly Quadrupled in 2015 -- Here's Why --

Why Exelixis, Inc. Is Trading Higher Today --

Stock markets Health

The FDA Approves Exelixis, Inc's New Cancer Drug --

Health